ArticleStroke and vascular neurology2024

Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial.

Shuya Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.